Subcutaneous Administration of Recombinant Human Granulocyte Colony‐stimulating Factor (KRN8601) in Intensive Chemotherapy for Patients with Advanced Lung Cancer

The efficacy and toxicity of recombinant human granulocyte colony‐stimulating factor (rh G‐CSF, KRN8601) given subcutaneously was evaluated in patients with advanced lung cancer undergoing intensive chemotherapy. Twenty‐nine and 30 patients with or without prior therapy were enrolled in this study....

Descripción completa

Detalles Bibliográficos
Autores principales: Eguchi, Kenji, Shinkai, Tetsu, Sasaki, Yasutsuna, Tamura, Tomohide, Ohe, Yuichiro, Nakagawa, Kazuhiko, Fukuda, Masaaki, Yamada, Kouzou, Kojima, Akira, Oshita, Fumihiro, Morita, Masashige, Suemasu, Keiichi, Saijo, Nagahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 1990
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917984/
https://www.ncbi.nlm.nih.gov/pubmed/1702415
http://dx.doi.org/10.1111/j.1349-7006.1990.tb02530.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917984/
https://www.ncbi.nlm.nih.gov/pubmed/1702415
http://dx.doi.org/10.1111/j.1349-7006.1990.tb02530.x

Ejemplares similares